Pharmacist recommendations in an intensive care unit: three-year clinical activities

Fideles, Giovanni Montini Andrade; Alcântara-Neto, José Martins de; Júnior, Arnaldo Aires Peixoto; Souza-Neto, Paulo José de; Tonete, Taís Luana; Silva, José Eduardo Gomes da; Néri, Eugenie Desirèe Rabelo

doi:10.5935/0103-507x.20150026

Cited by 16 publications

(16 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Studies conducted at university hospitals in Fortaleza (CE, Brazil), Curitiba (PR, Brazil), and in the Netherlands, also detected the need for management of dilution and infusion time, dose adjustment and drug withdrawal. ( 1 , 5 , 23 ) Costa, in a study carried out at a university hospital in Campinas (SP, Brazil), showed acceptance of 86.14% of pharmaceutical recommendations made in one year. ( 8 )…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results

Silva

Sousa

Perraud

et al. 2018

Einstein (São Paulo)

View full text Add to dashboard Cite

ObjectiveTo describe and evaluate the pharmacotherapeutic follow-up by a clinical pharmacist in an intensive care unit.MethodsA descriptive and cross-sectional study carried out from August to October 2016. The data were collected through a form, and pharmacotherapeutic follow-up conducted by a clinical pharmacist at the respiratory intensive care unit of a tertiary hospital. The problems recorded in the prescriptions were quantified, classified and evaluated according to severity; the recommendations made by the pharmacist were analyzed considering the impact on pharmacotherapy. The medications involved in the problems were classified according to the Anatomical Therapeutic Chemical Classification System.ResultsForty-six patients were followed up and 192 pharmacotherapy-related problems were registered. The most prevalent problems were missing information on the prescription (33.16%), and those with minor severity (37.5%). Of the recommendations made to optimize pharmacotherapy, 92.7% were accepted, particularly those on inclusion of infusion time (16.67%), and dose appropriateness (13.02%), with greater impact on toxicity (53.6%). Antimicrobials, in general, for systemic use were drug class most often related to problems in pharmacotherapy (53%).ConclusionPharmacotherapeutic follow-up conducted by a pharmacist in a respiratory intensive care unit was able to detect problems in drug therapy and to make clinically relevant recommendations.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Other studies have also shown these drugs to be the most frequently responsible for pharmacotherapy-related problems. ( 3 , 5 , 8 , 23 )…”

Section: Discussionmentioning

confidence: 99%

Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results

Silva

Sousa

Perraud

et al. 2018

Einstein (São Paulo)

View full text Add to dashboard Cite

show abstract

“…As a consequence, pharmacotherapy is established as a determining factor in the evolution of these patients. Errors related to medication use are more serious in this sector and are frequently related to fatal outcomes and/or requiring additional life support measures [3][4][5] .…”

Section: Rbfhss Revista Brasileira De Farmácia Hospitalar E Serviços mentioning

confidence: 99%

Description of a Comprehensive Medication Management service in an adult intensive care unit

Souza¹,

Nascimento²,

Oliveira³

et al. 2020

Rev Bras Farm Hosp Serv Saude

View full text Add to dashboard Cite

Objective: To describe the results of a Comprehensive Medication Management (CMM) service offered to patients of an adult intensive care unit. Methods: A descriptive cross-sectional study of the results of the CMM service (April 2017 to November 2018). All the patients followed up in the CMM service were included in the sample of this study. The service was integrally based on the Pharmaceutical Care Practice and, therefore, used the Pharmacotherapy Workup (PW) method. the drug therapy Problems (DTP) were quantified and classified according to the PW method. The main medications involved in the DTP were also described, as well as the acceptance of the interventions by the multidisciplinary care team members and patients. Results: 146 patients were followed up during the study period, and 512 DTP were identified. Of these DTP, most were related to medication safety (37.7%) and to indication (37.5%). The main causes were high dose (23.0%, with emphasis on dose adjustments in cases of kidney injury), need for additional medication (18.9%, inclusion of medication for electrolytic, glycemic, and prophylactic control), and unnecessary medication (18.6%, emphasis on de-prescription of antibiotics that were not indicated). Most of the problems (23.6%) were related to the therapeutic class of systemic anti-infective agent. Of the total DTP detected, 81.6% were resolved. A total of 451 interventions were implemented, of which 92.9% (n=419) were with physicians. The majority of the interventions with physicians were accepted (n=344, 82.1%). Conclusion: A high number of drug therapy problems have been detected and resolved by the CMM pharmacist, with emphasis on safety problems. The high acceptability of the interventions reinforces the need for the service applied to the critical patient.

show abstract

“…Merali et al, made many recommendations to reduce drug medication errors at different stages .Recommendations to reduce medication errors. Many organizations are now dedicated to patient safety" [18].…”

Section: These Are As Followsmentioning

confidence: 99%

“…This inding might be due to improvement of the clinical knowledge of the pharmacist and his/her more thorough integration with the ICU multi-professional staff. According to the BIOMEDICAL literature, pharmacist's actions in the ICU should not to be limited to providing advice to the equip but also include pro-active participation in decision-making in the maintenance of pharmacological treatment" [18].…”

Section: These Are As Followsmentioning

confidence: 99%

Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function

Luisetto¹

2017

J Clin Intensive Care Med

View full text Add to dashboard Cite

show abstract

Pharmacist recommendations in an intensive care unit: three-year clinical activities

Cited by 16 publications

References 17 publications

Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results

Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results

Description of a Comprehensive Medication Management service in an adult intensive care unit

Intensive Care Units (ICU): The clinical pharmacist role to improve clinical outcomes and reduce mortality rate- An undeniable function

Contact Info

Product

Resources

About